Back

Atrial fibrillation in patients with hypertrophic cardiomyopathy

27 August 2023 (17:15 - 18:00)
Organised by: Logo
Congress Presentation Part of: Cardiomyopathies in myocardial disease Hypertrophic Cardiomyopathy ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Christopher Ryan Zoerner

Herlev and Gentofte Hospital, Copenhagen (Denmark)

7 More presentations in this session

Presentation thumbnail
Changes in standard of care (SOC) medication during long-term mavacamten treatment for obstructive hypertrophic cardiomyopathy (HCM): results from the EXPLORER cohort of MAVA-Long-Term Extension (LTE)
Doctor N. Lakdawala (Boston, US)
Abstract Slides Video
Presentation thumbnail
Improvement in myocardial energetics and perfusion with Liraglutide in patients with type 2 diabetes- A randomised, single centre, open label, cross-over drug trial
Doctor H. Procter (Leeds, GB)
Abstract Slides Video
Presentation thumbnail
Electrocardiogram evolution in Anderson-Fabry disease patients during follow-up
Doctor M. Schiavo (Bologna, IT)
Abstract Slides Video
Presentation thumbnail
Association between hospital volume, clinical events, resource utilization, and costs of septal myectomy and alcohol septal ablation procedures in US patients with hypertrophic cardiomyopathy
Doctor E. Maksabedian Hernandez (Princeton, US)
Abstract Slides Video
Presentation thumbnail
Electrocardiographic evolution in Anderson-Fabry disease: a valuable tool to detect progressive cardiac involvement
Doctor R. Baldassarre (Bologna, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiomyopathies in myocardial disease

The Event

Event poster

ESC Congress 2023

27 August 2023 17:15 CET
You may be interested in
thumbnail
Congress Presentation
REDWOOD-HCM, SEQUOIA-HCM and FOREST-HCM trials: Incidence and impact of atrial fibrillation in oHCM with aficamten
thumbnail
Congress Presentation
Left atrial strain and peak left ventricular outflow gradient are the main predictors of atrial fibrillation in patients with hypertrophic cardiomyopathy
thumbnail
Congress Presentation
Polygenic risk score for prediction of atrial fibrillation according to presence of the hypertrophic cardiomyopathy

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources